Area of research
Pulmonary and Respiratory Medicine · Genetics
Research interest
Research interests include Pulmonary Hypertension Research and Treatments, Vascular Anomalies and Treatments, Cardiovascular Issues in Pregnancy, and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis.
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension
Pulmonary arterial hypertension in adults with Still’s disease: another pulmonary manifestation associated with HLA-DRB1*15
Chronic thromboembolic pulmonary disease
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study
Pulmonary vascular phenotype identified in patients with<i>GDF2</i>(<i>BMP9</i>) or<i>BMP10</i>variants: an international multicentre study
Characteristics and outcomes of patients developing pulmonary hypertension associated with proteasome inhibitors
Outcomes and risk assessment in pulmonary veno-occlusive disease
Chronic thromboembolic pulmonary hypertension: realising the potential of multimodal management
An emerging phenotype of pulmonary arterial hypertension patients carrying<i>SOX17</i>variants
COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort Study
Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension
External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry
Serum and pulmonary uric acid in pulmonary arterial hypertension
Outcomes of patients with decreased arterial oxyhaemoglobin saturation on pulmonary arterial hypertension drugs
ERS statement on chronic thromboembolic pulmonary hypertension
Portopulmonary hypertension in the current era of pulmonary hypertension management
Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease
Chronic thromboembolic pulmonary hypertension
Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension
Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis
Association between Rheumatoid Arthritis and Pulmonary Hypertension: Data from the French Pulmonary Hypertension Registry
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension
RETRACTED: Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study
Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension
Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study
Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension
Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension
Pulmonary veno-occlusive disease
Initial dual oral combination therapy in pulmonary arterial hypertension
Resting pulmonary artery pressure of 21–24 mmHg predicts abnormal exercise haemodynamics